
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1B | $2.1B | $2.6B | $3.2B | $3.7B | |
Revenue Growth (YoY) | -43.37% | 86.55% | 20.46% | 25.22% | 13.38% | |
Cost of Revenues | $974M | $1.5B | $1.8B | $2.2B | $2.5B | |
Gross Profit | $171M | $647M | $823M | $982M | $1.2B | |
Gross Profit Margin | 14.94% | 30.29% | 31.99% | 30.48% | 31.89% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $174M | $210M | $288M | $316M | $408M | |
Other Inc / (Exp) | -$123M | -$74M | $227M | $128M | -$167M | |
Operating Expenses | $615M | $607M | $650M | $685M | $773M | |
Operating Income | -$444M | $40M | $173M | $297M | $392M | |
Net Interest Expenses | $139M | $123M | $149M | $214M | $208M | |
EBT. Incl. Unusual Items | -$706M | -$157M | $251M | $211M | $17M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$112M | -$37M | -$311M | $27M | $47M | |
Net Income to Company | -$594M | -$120M | $562M | $184M | -$30M | |
Minority Interest in Earnings | -$2M | -$70M | -$4M | $1M | -- | |
Net Income to Common Excl Extra Items | -$596M | -$190M | $558M | $185M | -$30M | |
Basic EPS (Cont. Ops) | -$2.57 | -$0.82 | $2.39 | $0.79 | -$0.13 | |
Diluted EPS (Cont. Ops) | -$2.57 | -$0.82 | $2.15 | $0.62 | -$0.13 | |
Weighted Average Basic Share | $232M | $232M | $233M | $234M | $240M | |
Weighted Average Diluted Share | $238M | $240M | $244M | $240M | $243M | |
EBITDA | -$119M | $363M | $762M | $794M | $577M | |
EBIT | -$560M | -$34M | $400M | $425M | $225M | |
Revenue (Reported) | $1.1B | $2.1B | $2.6B | $3.2B | $3.7B | |
Operating Income (Reported) | -$444M | $40M | $173M | $297M | $392M | |
Operating Income (Adjusted) | -$560M | -$34M | $400M | $425M | $225M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $180M | $360M | $381M | $587M | $447M | |
Revenue Growth (YoY) | 361.54% | 100% | 5.83% | 54.07% | -23.85% | |
Cost of Revenues | $84M | $195M | $206M | $305M | $325M | |
Gross Profit | $96M | $165M | $175M | $282M | $122M | |
Gross Profit Margin | 53.33% | 45.83% | 45.93% | 48.04% | 27.29% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $43M | $56M | $75M | $93M | $104M | |
Other Inc / (Exp) | $73M | -$23M | -$80M | -$33M | $91M | |
Operating Expenses | $143M | $146M | $159M | $180M | $182M | |
Operating Income | -$47M | $19M | $16M | $102M | -$60M | |
Net Interest Expenses | $32M | $29M | $51M | $62M | $55M | |
EBT. Incl. Unusual Items | -$6M | -$33M | -$115M | $7M | -$24M | |
Earnings of Discontinued Ops. | -- | -- | -- | $241M | -- | |
Income Tax Expense | -$13M | $2M | -$6M | $3M | -$29M | |
Net Income to Company | $7M | -$35M | -$109M | $77M | $22M | |
Minority Interest in Earnings | -$53M | -- | -- | -$42M | -- | |
Net Income to Common Excl Extra Items | -$46M | -$35M | -$109M | $203M | $5M | |
Basic EPS (Cont. Ops) | -$0.20 | -$0.15 | -$0.47 | $0.33 | $0.09 | |
Diluted EPS (Cont. Ops) | -$0.20 | -$0.15 | -$0.58 | $0.32 | $0.05 | |
Weighted Average Basic Share | $232M | $232M | $234M | $235M | $249M | |
Weighted Average Diluted Share | $239M | $236M | $237M | $243M | $257M | |
EBITDA | $126M | $86M | $20M | $155M | $108M | |
EBIT | $26M | -$4M | -$64M | $69M | $31M | |
Revenue (Reported) | $180M | $360M | $381M | $587M | $447M | |
Operating Income (Reported) | -$47M | $19M | $16M | $102M | -$60M | |
Operating Income (Adjusted) | $26M | -$4M | -$64M | $69M | $31M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.3B | $2.3B | $2.6B | $3.4B | $3.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1B | $1.6B | $1.8B | $2.3B | $2.5B | |
Gross Profit | $271M | $716M | $833M | $1.1B | $1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $173M | $223M | $307M | $334M | $421M | |
Other Inc / (Exp) | $120M | -$170M | $170M | $175M | -$127M | |
Operating Expenses | $610M | $610M | $663M | $706M | $777M | |
Operating Income | -$339M | $106M | $170M | $383M | $228M | |
Net Interest Expenses | $125M | $120M | $171M | $225M | $208M | |
EBT. Incl. Unusual Items | -$344M | -$184M | $169M | $333M | -$107M | |
Earnings of Discontinued Ops. | -- | -- | -- | $241M | -- | |
Income Tax Expense | -$100M | -$22M | -$319M | $36M | -$5M | |
Net Income to Company | -$244M | -$162M | $488M | $370M | -$85M | |
Minority Interest in Earnings | -$55M | -$17M | -$4M | -$41M | -- | |
Net Income to Common Excl Extra Items | -$299M | -$179M | $484M | $497M | -$102M | |
Basic EPS (Cont. Ops) | -$1.29 | -$0.77 | $2.07 | $1.59 | -$0.38 | |
Diluted EPS (Cont. Ops) | -$1.29 | -$0.77 | $1.63 | $1.37 | -$0.42 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $225M | $323M | $696M | $929M | $444M | |
EBIT | -$212M | -$64M | $340M | $558M | $101M | |
Revenue (Reported) | $1.3B | $2.3B | $2.6B | $3.4B | $3.5B | |
Operating Income (Reported) | -$339M | $106M | $170M | $383M | $228M | |
Operating Income (Adjusted) | -$212M | -$64M | $340M | $558M | $101M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $180M | $360M | $381M | $587M | $447M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $84M | $195M | $206M | $305M | $325M | |
Gross Profit | $96M | $165M | $175M | $282M | $122M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $43M | $56M | $75M | $93M | $104M | |
Other Inc / (Exp) | $73M | -$23M | -$80M | -$33M | $91M | |
Operating Expenses | $143M | $146M | $159M | $180M | $182M | |
Operating Income | -$47M | $19M | $16M | $102M | -$60M | |
Net Interest Expenses | $32M | $29M | $51M | $62M | $55M | |
EBT. Incl. Unusual Items | -$6M | -$33M | -$115M | $7M | -$24M | |
Earnings of Discontinued Ops. | -- | -- | -- | $241M | -- | |
Income Tax Expense | -$13M | $2M | -$6M | $3M | -$29M | |
Net Income to Company | $7M | -$35M | -$109M | $77M | $22M | |
Minority Interest in Earnings | -$53M | -- | -- | -$42M | -- | |
Net Income to Common Excl Extra Items | -$46M | -$35M | -$109M | $203M | $5M | |
Basic EPS (Cont. Ops) | -$0.20 | -$0.15 | -$0.47 | $0.33 | $0.09 | |
Diluted EPS (Cont. Ops) | -$0.20 | -$0.15 | -$0.58 | $0.32 | $0.05 | |
Weighted Average Basic Share | $232M | $232M | $234M | $235M | $249M | |
Weighted Average Diluted Share | $239M | $236M | $237M | $243M | $257M | |
EBITDA | $126M | $86M | $20M | $155M | $108M | |
EBIT | $26M | -$4M | -$64M | $69M | $31M | |
Revenue (Reported) | $180M | $360M | $381M | $587M | $447M | |
Operating Income (Reported) | -$47M | $19M | $16M | $102M | -$60M | |
Operating Income (Adjusted) | $26M | -$4M | -$64M | $69M | $31M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.7B | $2.1B | $1.7B | $1.4B | $2.6B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $121M | $66M | $123M | $123M | $114M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $459M | $229M | $167M | $180M | $277M | |
Total Current Assets | $2.3B | $2.4B | $2B | $1.7B | $3B | |
Property Plant And Equipment | $124M | $119M | $408M | $838M | $810M | |
Long-Term Investments | $207M | $221M | $253M | $41M | $33M | |
Goodwill | $4B | $4B | $4B | $4B | $4.1B | |
Other Intangibles | $3.9B | $3.5B | $3.2B | $2.9B | $2.7B | |
Other Long-Term Assets | $757M | $1.5B | $1.2B | $255M | $494M | |
Total Assets | $11.2B | $11.7B | $11B | $10.3B | $11.8B | |
Accounts Payable | $150M | $308M | $396M | $472M | $645M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | $36M | $26M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $17M | $23M | $29M | $32M | $192M | |
Total Current Liabilities | $692M | $1.3B | $833M | $787M | $1.1B | |
Long-Term Debt | $3.6B | $2.9B | $2.9B | $2.9B | $3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.6B | $4.7B | $4.1B | $3.8B | $4.4B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $6.6B | $6.3B | $6.9B | $6.4B | $7.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $5M | $600M | $25M | -- | -- | |
Total Equity | $6.6B | $6.9B | $6.9B | $6.4B | $7.4B | |
Total Liabilities and Equity | $11.2B | $11.7B | $11B | $10.3B | $11.8B | |
Cash and Short Terms | $1.7B | $2.1B | $1.7B | $1.4B | $2.6B | |
Total Debt | $3.8B | $3.6B | $2.9B | $2.9B | $3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.8B | $2.3B | $1.6B | $1.2B | $2.8B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $141M | $148M | $91M | $175M | $143M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $544M | $209M | $278M | $338M | $376M | |
Total Current Assets | $2.5B | $2.6B | $2B | $1.7B | $3.4B | |
Property Plant And Equipment | $121M | $125M | $504M | $834M | $825M | |
Long-Term Investments | $244M | $216M | $265M | $38M | $31M | |
Goodwill | $4B | $4B | $4B | $4.2B | $4.1B | |
Other Intangibles | $3.8B | $3.4B | $3.1B | $2.9B | $2.6B | |
Other Long-Term Assets | $1.4B | $1.5B | $1.2B | $899M | $512M | |
Total Assets | $12B | $11.9B | $11B | $10.6B | $12.1B | |
Accounts Payable | $167M | $225M | $318M | $396M | $330M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $30M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $39M | $37M | $35M | $47M | $77M | |
Total Current Liabilities | $964M | $1.5B | $998M | $1.1B | $1.4B | |
Long-Term Debt | $3.5B | $2.9B | $2.9B | $2.9B | $3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.9B | $5B | $4.1B | $4.1B | $4.7B | |
Common Stock | -- | -- | -- | -- | $3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $581M | $600M | $25M | -- | -- | |
Total Equity | $7.1B | $6.9B | $6.8B | $6.5B | $7.4B | |
Total Liabilities and Equity | $12B | $11.9B | $11B | $10.6B | $12.1B | |
Cash and Short Terms | $1.8B | $2.3B | $1.6B | $1.2B | $2.8B | |
Total Debt | $3.8B | $3.7B | $3B | $2.9B | $3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$594M | -$120M | $562M | $184M | -$30M | |
Depreciation & Amoritzation | $441M | $397M | $362M | $369M | $352M | |
Stock-Based Compensation | $21M | $29M | $16M | $20M | $30M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$139M | $481M | $534M | $619M | $567M | |
Capital Expenditures | $21M | $17M | $291M | $426M | $75M | |
Cash Acquisitions | $88M | -$140M | -$43M | -$173M | -$212M | |
Cash From Investing | $75M | -$600M | $394M | -$510M | -$292M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.3B | -- | $2.9B | -- | $645M | |
Long-Term Debt Repaid | -$614M | -$322M | -$3.6B | -$70M | -$677M | |
Repurchase of Common Stock | -$69M | -$55M | -$616M | -- | -- | |
Other Financing Activities | $570M | $314M | $27M | -$365M | $58M | |
Cash From Financing | $1.2B | $512M | -$1.3B | -$435M | $965M | |
Beginning Cash (CF) | $587M | $1.7B | $2.1B | $1.7B | $1.4B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.1B | $393M | -$341M | -$326M | $1.2B | |
Ending Cash (CF) | $1.7B | $2.1B | $1.7B | $1.4B | $2.6B | |
Levered Free Cash Flow | -$160M | $464M | $243M | $193M | $492M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7M | -$35M | -$109M | $77M | $22M | |
Depreciation & Amoritzation | $100M | $90M | $84M | $86M | $77M | |
Stock-Based Compensation | $6M | $3M | $5M | $12M | $2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $184M | $135M | $257M | $140M | $391M | |
Capital Expenditures | $3M | $10M | $62M | $27M | $33M | |
Cash Acquisitions | -$53M | -$3M | -$96M | -$206M | -$136M | |
Cash From Investing | -$631M | $63M | -$159M | -$296M | -$180M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$3M | -$1M | -$53M | -$10M | -$6M | |
Repurchase of Common Stock | -- | -$37M | -- | -- | -- | |
Other Financing Activities | -$24M | $33M | -$196M | -$1M | -$7M | |
Cash From Financing | $548M | -$5M | -$249M | -$11M | -$13M | |
Beginning Cash (CF) | $1.7B | $2.1B | $1.7B | $1.4B | $2.6B | |
Foreign Exchange Rate Adjustment | -$2M | -$2M | $2M | -- | $4M | |
Additions / Reductions | $101M | $193M | -$151M | -$167M | $198M | |
Ending Cash (CF) | $1.8B | $2.3B | $1.6B | $1.2B | $2.8B | |
Levered Free Cash Flow | $181M | $125M | $195M | $113M | $358M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$244M | -$162M | $488M | $370M | -$85M | |
Depreciation & Amoritzation | $437M | $387M | $356M | $371M | $343M | |
Stock-Based Compensation | $21M | $26M | $18M | $27M | $20M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$91M | $432M | $656M | $502M | $818M | |
Capital Expenditures | $22M | $24M | $343M | $391M | $81M | |
Cash Acquisitions | -$69M | -$90M | -$136M | -$283M | -$142M | |
Cash From Investing | -$666M | $94M | $172M | -$647M | -$176M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $2.9B | -- | -- | |
Long-Term Debt Repaid | -$486M | -$320M | -$3.6B | -$27M | -$673M | |
Repurchase of Common Stock | -- | -$92M | -$579M | -- | -- | |
Other Financing Activities | $552M | $371M | -$202M | -$170M | $52M | |
Cash From Financing | $1.4B | -$41M | -$1.5B | -$197M | $963M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $680M | $485M | -$685M | -$342M | $1.6B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$113M | $408M | $313M | $111M | $737M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7M | -$35M | -$109M | $77M | $22M | |
Depreciation & Amoritzation | $100M | $90M | $84M | $86M | $77M | |
Stock-Based Compensation | $6M | $3M | $5M | $12M | $2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $184M | $135M | $257M | $140M | $391M | |
Capital Expenditures | $3M | $10M | $62M | $27M | $33M | |
Cash Acquisitions | -$53M | -$3M | -$96M | -$206M | -$136M | |
Cash From Investing | -$631M | $63M | -$159M | -$296M | -$180M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$3M | -$1M | -$53M | -$10M | -$6M | |
Repurchase of Common Stock | -- | -$37M | -- | -- | -- | |
Other Financing Activities | -$24M | $33M | -$196M | -$1M | -$7M | |
Cash From Financing | $548M | -$5M | -$249M | -$11M | -$13M | |
Beginning Cash (CF) | $1.7B | $2.1B | $1.7B | $1.4B | $2.6B | |
Foreign Exchange Rate Adjustment | -$2M | -$2M | $2M | -- | $4M | |
Additions / Reductions | $101M | $193M | -$151M | -$167M | $198M | |
Ending Cash (CF) | $1.8B | $2.3B | $1.6B | $1.2B | $2.8B | |
Levered Free Cash Flow | $181M | $125M | $195M | $113M | $358M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.